21-FEB-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 651 17 887 73 889 126 767
ERLYTX 63 2 104 8 97 18 110
GI 217 4 209 17 207 27 164
GU 534 8 417 37 450 79 481
LEUK 80 2 104 12 146 23 140
LUNG 719 3 157 14 170 18 110
LYMPH 263 4 209 42 511 61 371
MELAN 434 8 417 34 414 40 244
MMYEL 331 4 209 20 244 51 310
MULT 27 0 0 0 0 0 0
OTHER 56 0 0 2 24 5 30
PREV 6 0 0 0 0 0 0
SXQOL 6 0 0 0 0 0 0
Total 3387 52 2713 259 3152 448 2727

21-FEB-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 641 0 0 10 122 18 110
ERLYTX 5 0 0 0 0 0 0
GU 4 0 0 0 0 0 0
LEUK 328 9 470 87 1059 139 846
LUNG 291 4 209 22 268 34 207
OTHER 16 1 52 2 24 3 18
PEOLC 13 0 0 8 97 13 79
PREV 435 1 52 8 97 15 91
SXQOL 914 12 626 38 463 102 621
Total 2647 27 1409 175 2130 324 1972

21-FEB-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 651 17 887 73 889 126 767
CCD 641 0 0 10 122 18 110
ERLYTX 68 2 104 8 97 18 110
GI 217 4 209 17 207 27 164
GU 538 8 417 37 450 79 481
LEUK 408 11 574 99 1205 162 986
LUNG 1010 7 365 36 438 52 317
LYMPH 263 4 209 42 511 61 371
MELAN 434 8 417 34 414 40 244
MMYEL 331 4 209 20 244 51 310
MULT 27 0 0 0 0 0 0
OTHER 72 1 52 4 49 8 49
PEOLC 13 0 0 8 97 13 79
PREV 441 1 52 8 97 15 91
SXQOL 920 12 626 38 463 102 621
Total 6034 79 4121 434 5283 772 4700

21-FEB-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 372 10 522 41 499 67 408
ERLYTX 38 1 52 3 37 8 49
GI 178 4 209 12 146 19 116
GU 459 7 365 33 402 68 414
LEUK 54 1 52 8 97 18 110
LUNG 442 3 157 11 134 13 79
LYMPH 190 3 157 27 329 40 244
MELAN 250 4 209 21 256 25 152
MMYEL 210 3 157 12 146 37 225
MULT 15 0 0 0 0 0 0
OTHER 56 0 0 2 24 5 30
PREV 6 0 0 0 0 0 0
SXQOL 6 0 0 0 0 0 0
Total 2276 36 1880 170 2070 300 1827

21-FEB-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 539 0 0 10 122 17 103
ERLYTX 5 0 0 0 0 0 0
GU 4 0 0 0 0 0 0
LEUK 151 4 209 39 475 73 444
LUNG 151 2 104 9 110 12 73
OTHER 16 1 52 2 24 3 18
PEOLC 10 0 0 6 73 10 61
PREV 368 1 52 8 97 15 91
SXQOL 608 8 417 29 353 71 432
Total 1852 16 834 103 1254 201 1222

21-FEB-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 506 13 678 51 621 88 536
CCD 560 2 104 13 158 19 116
ERLYTX 43 1 52 3 37 8 49
GI 181 4 209 9 110 19 116
GU 478 6 313 34 414 66 402
LEUK 205 5 261 47 572 91 554
LUNG 593 5 261 20 244 25 152
LYMPH 190 3 157 27 329 40 244
MELAN 250 4 209 21 256 25 152
MMYEL 217 1 52 2 24 39 237
MULT 16 0 0 0 0 0 0
OTHER 146 6 313 22 268 42 256
PEOLC 17 1 52 5 61 13 79
PREV 374 1 52 8 97 15 91
SURV 1 0 0 0 0 1 6
SXQOL 614 8 417 29 353 71 432
Total 4391 60 3130 291 3544 562 3422

21-FEB-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 580 13 678 64 779 113 688
ERLYTX 61 2 104 8 97 18 110
GI 103 1 52 9 110 13 79
GU 240 5 261 16 195 40 244
LEUK 57 2 104 11 134 17 103
LUNG 688 3 157 11 134 15 91
LYMPH 183 3 157 32 390 48 292
MELAN 6 0 0 0 0 0 0
MMYEL 316 4 209 20 244 51 310
MULT 27 0 0 0 0 0 0
Total 2261 33 1722 171 2083 315 1917

21-FEB-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 2103 23 1200 157 1911 284 1729
AFFIL 225 2 104 6 73 12 73
CCOP/NCORP 1800 27 1409 110 1339 205 1248
Non-SWOG 1903 24 1252 158 1924 268 1631
Total 6031 76 3965 431 5247 769 4681

21-FEB-2025 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
PEOLC S2408 Panc, Lanreotide 1 Y 14-FEB-25

21-FEB-2025 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
OTHER ARST2031 RMS, Stg IV, VINO-AC+VINO-CPO vs VAC+VINO-CPO 1 E 31-JAN-25
MELAN EA6194 Melan, Stage IIIB-D, Pembro +/- CMP-001 1 E 28-JAN-25

21-FEB-2025 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 13
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 10
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 9
MELAN S2015 MELAN, Stg I-II, 1cm v 2cm excision margins 1 8
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 7
OTHER 10323 Moonshot Biobank Research 1 5
LUNG LUNGMAP NSCLC, Adv, Master 1 4
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 4
GU EA8212 Blad, NMIBC, BRIDGE 1 3
CCD S1703 Met Breast, STM-monitoring v Usual Care 1 3
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 2 3
LUNG S1827 SCLC, MRI Surveillance +/- PCI 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3